跳至主要内容
临床试验/PACTR202011872201172
PACTR202011872201172已完成4 期

EFFECT OF INTRAVENOUS TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING AND AFTER ELECTIVE CAESAREAN SECTION IN THE UNIVERSITY OF PORT HARCOURT TEACHING HOSPITAL: A RANDOMIZED CONTROLLED STUDY

JEMIRIGBE OMAWUMI DARLINGTO0 个研究点目标入组 148 人开始时间: 2020年11月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Age between 20 to 40 years.
  • Parity- 1 - 4
  • Gestational age of 37-40 weeks.
  • Singleton live fetus with reassuring fetal heart rate.
  • Elective repeat CS.

排除标准

  • Refusal of the patient to give consent.
  • Known allergy to intravenous tranexamic acid.
  • Multiple pregnancies.
  • Antepartum haemorrhage.
  • Co-existing uterine fibroids.
  • Macrosomic baby- birth weight =4kg.
  • Intrauterine fetal death.
  • Preeclampsia.
  • Others are history of thromboembolic disease, medical conditions such as major liver, heart, kidney, brain and bleeding disorders, anticoagulant therapy, patients requiring blood transfusion due to anaemia and polyhydramnios. The medical conditions will be excluded from thorough history and examination of the patient and those with a positive history and examination findings suggestive of these medical conditions will be excluded from the study.

研究者

发起方
JEMIRIGBE OMAWUMI DARLINGTO

相似试验